Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874236 · ClinicalTrials.gov registry record · Phase 4
Validity and Reliability of Diagnostic Findings of SI Joint Blocking
A Phase 4 study, sponsored by SI-BONE.
- Terminated
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT01874236: Clinical Trial Phase 4 study, sponsored by SI-BONE.
NCT01874236 is a Phase 4 study that was terminated before completion, run by SI-BONE. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874236, a Phase 4 study, was terminated before completion, sponsored by SI-BONE.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the trial is to confirm the validity and reliability of diagnostic SI joint blocks.
Interventions
- DRUG 0.75% bupivacaine
- DRUG .75% bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04-22 |
| Est. Completion | 2014-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01874236
The ClinicalTrials.gov registry entry for NCT01874236 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SI-BONE, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0.75% bupivacaine is the first listed.
NCT01874236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01874236 about?
NCT01874236 is a clinical study titled "Validity and Reliability of Diagnostic Findings of SI Joint Blocking". The purpose of the trial is to confirm the validity and reliability of diagnostic SI joint blocks.
What is the current status of trial NCT01874236?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2013-04-22. Estimated completion is 2014-09-30.
What interventions are being tested in trial NCT01874236?
The interventions under investigation include: 0.75% bupivacaine (DRUG), .75% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01874236?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.